LRG和NGAL是炎症性肠病的潜在诊断和疾病活动生物标志物
Dongdan Zhang1, Yue Meng2, Dan Li3
1Department of Transfusion Medicine, Huizhou First Hospital, Huizhou, Guangdong, China; Shantou University Medical College, Shantou, Guangdong, China.
富含血清白蛋白的α-2糖蛋白 (LRG) 和与中性粒细胞凝酶相关的卡林 (NGAL) 显示为诊断炎症性肠病 (IBD) 和评估疾病活性的生物标志物具有前途.
科学领域:
- 胃肠病学 胃肠病学
- 生物标志物发现发现
- 临床诊断 临床诊断 临床诊断
背景情况:
- 炎症性肠病 (IBD) 的诊断和监测需要可靠的生物标志物.
- 中性粒细胞凝酶相关的卡林 (NGAL) 和富含白的血清α-2糖蛋白 (LRG) 是潜在的候选物.
- 在IBD中NGAL和LRG的比较诊断疗效仍未得到充分研究.
研究的目的:
- 研究NGAL和LRG在诊断IBD中的临床实用性.
- 评估它们在评估IBD疾病活动中的作用.
- 为了比较NGAL和LRG的诊断性能.
主要方法:
- 招募了100名IBD患者 (75名克罗恩氏病患者,25名性结肠炎患者) 和100名健康对照.
- 使用酶相关免疫吸收试验 (ELISA) 量化血清NGAL和LRG度.
- 用户接收器操作特征 (ROC) 曲线分析以评估诊断性能.
主要成果:
- 与对照组相比,IBD患者的血清NGAL和LRG水平显著升高 (P < 0.001).
- 血清LRG显示出对IBD (AUC 0.90) 和NGAL (AUC 0.84) 的更高的诊断能力.
- 这两种生物标志物都与克罗恩病患者的疾病活性有很强的相关性,并且随着严重程度的增加而增加.
结论:
- 血清NGAL和LRG是IBD诊断的有价值的潜在生物标志物.
- 这些生物标志物还显示出监测IBD疾病活动的巨大潜力.
- 这些发现支持NGAL和LRG在IBD管理中的临床应用.
更多相关视频
09:04Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
